Acceptance on the move: Public reaction to shifting vaccination realities

Human Vaccines

Volumn 7, Issue 12, 2011, Pages 1261-1270

  Velan, Baruch ^a  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

Acceptance; Coverage; H1N1; Hesitancy; HPV; MMR; Varicella

Indexed keywords

CHICKENPOX VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; WART VIRUS VACCINE;

2009 H1N1 INFLUENZA; ANUS CANCER; ATTITUDE TO HEALTH; AUTISM; AWARENESS; BACTERIAL TRANSMISSION; BEHAVIOR CHANGE; CHICKENPOX; CONDYLOMA ACUMINATUM; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFECT; DRUG SAFETY; ENTERITIS; HUMAN; INFECTION SENSITIVITY; INFLUENZA VACCINATION; MASS IMMUNIZATION; MEASLES VACCINATION; MEN'S HEALTH; MOTIVATION; MOUTH CANCER; NONHUMAN; PANDEMIC INFLUENZA; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PUBLIC OPINION; PUBLIC RELATIONS; RESPONSIBILITY; REVIEW; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; WART VIRUS;

CHICKENPOX VACCINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA VACCINES; MALE; MEASLES-MUMPS-RUBELLA VACCINE; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 84855161680     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.12.17980     Document Type: Review

References (127)

1. Health at a glance: Childhood vaccination programmes. OECDiLibrary 2010; available at 10.1787/health-glance-2010-en.
2. Mills E, Jadad AR, Ross C, Wilson K. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol 2005; 58:1081-8; PMID:16223649; http://dx.doi.org/10.1016/j.jclinepi.2005.09.002.
3. Falagas ME, Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin 2008; 24:1719-41; PMID:18474148; http://dx.doi.org/10.1185/ 03007990802085692.
4. Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Long SJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine 2010; 28:4235-48; PMID:20438879; http://dx.doi.org/10.1016/j.vaccine.2010.04.052.
5. Lawrence GL, MacIntyre CR, Hull BP, McIntyre PB. Effectiveness of the linkage of child care and maternity payments to childhood immunisation. Vaccine 2004; 22:2345-50; PMID:15149795; http://dx.doi.org/10.1016/j.vaccine.2003.10. 038.
6. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360:1981-8; PMID:19420367; http://dx.doi.org/10.1056/NEJMsa0806477.
7. Kata A. A postmodern Pandora's box: anti-vaccination misinformation on the Internet. Vaccine 2010; 28:1709-16; PMID:20045099; http://dx.doi.org/10. 1016/j.vaccine.2009.12.022.
8. Leask J. Target the fence-sitters. Nature 2011; 473:443-5; PMID:21614055; http://dx.doi.org/10.1038/473443a.
9. Smith MJ, Marshall GS. Navigating parental vaccine hesitancy. Pediatr Ann 2010; 39:476-82; PMID:20704143; http://dx.doi.org/10.3928/00904481-20100726-05.
10. Limb M. "Vaccine hesitancy" means scientists need to be more honest about risks. BMJ 2011; 342:2479; PMID:21498466; http://dx.doi.org/10. 1136/bmj.d2479.
11. Stefanoff P, Mamelund SE, Robinson M, Netterlid E, Tuells J, Bergsaker MA, et al. Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC). Vaccine 2010; 28:5731-7; PMID:20558250; http://dx.doi.org/10.1016/j.vaccine. 2010.06.009.
12. Smith PJ, Humiston SG, Parnell T, Vannice KS, Salmon DA. The association between intentional delay of vaccine administration and timely childhood vaccination coverage. Public Health Rep 2010; 125:534-41; PMID:20597453.
13. Bhattacharyya S, Bauch CT. "Wait and see" vaccinating behaviour during a pandemic: A game theoretic analysis. Vaccine 2011; In press; PMID:21601606; http://dx.doi.org/10.1016/j.vaccine.2011.05.028.
14. Albert MR, Ostheimer KG, Breman JG. The last smallpox epidemic in Boston and the vaccination controversy 1901-1903. N Engl J Med 2001; 344:375-9; PMID:11172172; http://dx.doi.org/10.1056/NEJM200102013440511.
15. Bonah C. The 'experimental stable' of the BCG vaccine: safety, efficacy, proof and standards 1921-1933. Stud Hist Philos Biol Biomed Sci 2005; 36:696-721; PMID:16337557.
16. Baker JP. The pertussis vaccine controversy in Great Britain, 1974-1986. Vaccine 2003; 21:4003-10; PMID:12922137; http://dx.doi.org/10.1016/S0264- 410X(03)00302-5.
17. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. [Retraction in: Lancet 2010; 375:445]. Lancet 1998; 351:637-41; PMID:9500320; http://dx.doi.org/10.1016/S0140-6736(97) 11096-0.
18. Demicheli V, Jefferson T, Rivetti A, Price D. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2005; 4:4407; PMID:16235361.
19. Health Protection Agency. Annual COVER report: 2005/06 Summary of trends in vaccination coverage in the UK. Available: http://www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1194947367316.
20. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003; 301:804; PMID:12907792; http://dx.doi.org/10.1126/science.1086726.
21. D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 2006; 118:1664-75; PMID:17015560; http://dx.doi.org/10. 1542/peds.2006-1262.
22. Demicheli V, Jefferson T, Rivetti A, Price D. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2005; 4407; PMID:16235361.
23. Health protection Agency pressrelease 2011; http://www.hpa.org.uk/ NewsCentre/NationalPressReleases/2011PressReleases/110624Measlesstatement.
24. WHO position papers-Varicella vaccines. Weekly Epidemiological Record 1998; 73:241-8; http://www.who.int/docstore/wer/pdf/1998/wer7332.pdf.
25. Measles vaccines (Weekly Epidemiological Record 2009; 84:349-60; http://www.who.int/wer/2009/wer8435.pdf) .
26. Burgess DC, Margaret A, Burgess MA, Leask J. The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication? Vaccine 2006; 24:3921-8; PMID:16564116; http://dx.doi.org/10.1016/j.vaccine.2006.02.033.
27. Smith MJ, Marshall GS. Navigating parental vaccine hesitancy. Pediatr Ann 2010; 39:476-82; PMID:20704143; http://dx.doi.org/10.3928/00904481-20100726-05.
28. Hobson-West P. 'Trusting blindly can be the biggest risk of all': organised resistance to childhood vaccination in the UK. Sociol Health Illn 2007; 29:198-215; PMID:17381813; http://dx.doi.org/10.1111/j.1467-9566.2007. 00544.x.
29. Anderberg D, Chevalier A, Wadsworth J. Anatomy of a health scare: Education, income and the MMR controversy in the UK. J Health Econ 2011; 30:515-30; PMID:21439663; http://dx.doi.org/10.1016/j.jhealeco.2011.01.009.
30. Pearce A, Law C, Elliman D, Cole TJ, Bedford H. Factors associated with uptake of measles, mumps and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. BMJ 2008; 336:754-7; PMID:18309964; http://dx.doi.org/10.1136/bmj.39489.590671.25.
31. Flynn M, Ogden J. Predicting uptake of MMR vaccination: a prospective questionnaire study. Br J Gen Pract 2004; 54:526-30; PMID:15239915.
32. Cassell JA, Leach M, Poltorak MS, Mercer CH, Iversen A. Fairhead JRIs the cultural context of MMR rejection a key to an effective public health discourse? Public Health 2006; 120:783-94; PMID:16828492; http://dx.doi.org/10. 1016/j.puhe.2006.03.011.
33. Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006; 24:177-84; PMID:16157422; http://dx.doi.org/10.1016/j.vaccine.2005.07.063.
34. Smith A, Yarwood J, Salisbury DM. Tracking mothers' attitudes to MMR immunisation 1996-2006. Vaccine 2007; 25:3996-4002; PMID:17395344; http://dx.doi.org/10.1016/j.vaccine.2007.02.071.
35. Skea ZC, Entwistle VA, Watt I, Russell E. 'Avoiding harm to others' considerations in relation to parental measles, mumps and rubella (MMR) vaccination discussions-an analysis of an online chat forum. Soc Sci Med 2008; 67:1382-90; PMID:18703263; http://dx.doi.org/10.1016/j.socscimed.2008.07.006.
36. Brown KF, Shanley R, Cowley NA, van Wijgerden J, Toff P, Falconer M, et al. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument. Vaccine 2011; 29:1700-9; PMID:21185850; http://dx.doi.org/10.1016/j. vaccine.2010.12.030.
37. Brown K, Fraser G, Ramsay M, Shanley R, Cowley N, van Wijgerden J, et al. Attitudinal and Demographic Predictors of Measles-Mumps-Rubella Vaccine (MMR) Uptake during the UK Catch-Up Campaign 2008-09: Cross-Sectional Survey. PLoS ONE 2011; 6:19381; PMID:21602931; http://dx.doi.org/10.1371/journal.pone.0019381.
38. Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev 2005; 18:70-80; PMID:15653819; http://dx.doi.org/10.1128/CMR.18.1. 70-80.2005.
39. Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines 2010; 9:21-6; PMID:20192714; http://dx.doi.org/10.1586/erv.10.30.
40. Gershon AA. Vaccination against varicella: what's the point? Adv Exp Med Biol 2010; 659:83-7; PMID:20204757; http://dx.doi.org/10.1007/978-1-4419-0981-7- 7.
41. van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011; 29:2411-20; PMID:21277405; http://dx.doi.org/10.1016/j.vaccine.2011.01.037.
42. Lopez AS, Kolasa MS, Seward JF. Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program. J Infect Dis 2008; 197:76-81; PMID:18419414; http://dx.doi.org/10.1086/522139.
43. Public Health agency of Canada publications: Varicella Vaccination Two-Dose Recommendations. National Advisory Committee on Immunization Volume 36 ACS-8 September 2010. Available at http://www.phacaspc.gc.ca/publicat/ccdr-rmtc/ 10vol36/acs-8/index-eng.php.
44. Macartney KK, Burgess MA. Varicella vaccination in Australia and New Zealand. J Infect Dis 2008; 197:191-5; PMID:18419396; http://dx.doi.org/10.1086/ 522157.
45. Miron E, Abu-Foul N, Rishpon S. Factors affecting Varicella vaccine uptake among children 1-17 years old in the Haifa District in 2007. Hum Vaccin 2010; 6:849-53; PMID:20930562; http://dx.doi.org/10.4161/hv.6.10.12691.
46. Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, et al. Varicella vaccination in Japan, South Korea and Europe. J Infect Dis 2008; 197:185-90; PMID:18419395; http://dx.doi.org/10.1086/522163.
47. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009; 7:26; PMID:19476611; http://dx.doi.org/10.1186/1741-7015-7-26.
48. Reuss AM, Feig M, Kappelmayer L, Siedler A, Eckmanns T, Poggensee G. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health 2010; 10:502; PMID:20723217; http://dx.doi.org/10.1186/1471- 2458-10-502.
49. Streng A, Seeger K, Grote V, Liese JG. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004. Vaccine 2010; 28:5738-45; PMID:20600490; http://dx.doi.org/10.1016/j.vaccine.2010.06.007.
50. Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report 2008. Commun Dis Intell 2010; 34:241-58; PMID:21090180.
51. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine 2008; 26:6006-12; PMID:18761386; http://dx.doi.org/10.1016/j.vaccine.2008.08.016.
52. Gustafson R, Skowronski DM. Disparities in varicella vaccine coverage in the absence of public funding. Vaccine 2005; 23:3519-25; PMID:15855010; http://dx.doi.org/10.1016/j.vaccine.2005.02.001.
53. Marshall H, Ryan P, Roberton D. Uptake of varicella vaccine-a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005; 23:5389-97; PMID:16039020; http://dx.doi.org/10.1016/j.vaccine.2005.05.033.
54. Bedford H, Lansley M. More vaccines for children? Parents' views. Vaccine 2007; 25:7818-23; PMID:17920170; http://dx.doi.org/10.1016/j.vaccine.2007.08. 057.
55. Gust DA, Strine TW, Maurice E, Smith P, Yusuf H, Wilkinson M, et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 2004; 114:16-22; PMID:15231968; http://dx.doi.org/10.1542/peds.114.1.e16.
56. Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med 2005; 159:470-6; PMID:15867122; http://dx.doi.org/10.1001/archpedi.159.5.470.
57. Michaelis M, Doerr HW, Cinatl J. An influenza A H1N1 virus revival - pandemic H1N1/09 virus. Infection 2009; 37:381-9; PMID:19768379; http://dx.doi.org/10.1007/s15010-009-9181-5.
58. st century. Eur J Immunol 2009; 39:2946-54; PMID:19790188; http://dx.doi.org/10.1002/eji.200939911.
59. World Health Organization. Pandemic (H1N1) 2009 -update 66. www.who.int/csr/don/2009.09.18/en/index.html.
60. Rambhia KJ, Nuzzo J. H1N1: International Progress in Vaccine Development and Distribution, www.upmc-biosecurity.org, www.upmc-cbn.org, December 17, 2009.
61. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 2010; 28:4895-902; PMID:20553769; http://dx.doi.org/10.1016/j.vaccine.2010.05.031.
62. Walter D, Böhmer MM, Heiden M, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine 2011; 29:4008-12; PMID:21463683; http://dx.doi.org/10.1016/j.vaccine.2011.03.069.
63. Vaux S, van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, de Valk H, et al. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 2011; 11:30; PMID:21226919; http://dx.doi.org/10.1186/1471-2458-11-30.
64. CDC estimates of 2009 H1N1 cases, hospitalizations and deaths in the United States, April 2009-March 13, 2010. Atlanta: Centers for Disease Control and Prevention, April 2010, at: http://www.cdc.gov/h1n1flu/estimates-2009-h1n1. htm#Table%20Cumulative.
65. Wilde JAA. H1N1 'Swine Flu' 2009/2010: Where We've Been, What We Now Know Where We May Be Heading. Emerg Med Rep 2010; 15:1-2.
66. Seale H, Heywood AE, McLaws ML, Ward F, Lowbridge CP, Van D, et al. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis 2010; 10:99; PMID:20403201; http://dx.doi.org/10. 1186/1471-2334-10-99.
67. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med 2010; 362:65; PMID:20484390; http://dx.doi.org/10.1056/NEJMp1005102.
68. Sypsa V, Livanios T, Psichogiou M, Malliori M, Tsiodras S, Nikolakopoulos I, et al. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill 2009; 14:19437; PMID:20003909.
69. Eastwood K, Durrheim DN, Jones A, Butler M. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust 2010; 192:33-6; PMID:20047546.
70. Schwarzinger M, Verger P, Guerville MA, Aubry C, Rolland S, Obadia Y, et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public. Vaccine 2010; 28:2743-8; PMID:20117271; http://dx.doi.org/10.1016/j.vaccine.2010.01.027.
71. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ 2009; 339:4164; PMID:19861377; http://dx.doi.org/10.1136/bmj.b4164.
72. Lagarde JC, Door JC. [Report on behalf of the Investigating Committe on the way in which the influenza A (H1N1) vaccination campaign was planned, justified and managed]. Rapport fait de la commission d'enquête sur la manière dont a été programmé, expliquée et gérée la campagne de vaccination contre la grippe A(H1N1) Assemblée nationale. Paris 2010. http://www.assemblee-nationale.fr/13/ pdf/rap-enq/r2698.pdf accessed on July 30, 2010 [in French].
73. Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis 2011; 52:1203-11; PMID:21507917; http://dx.doi.org/10.1093/cid/cir182.
74. Poland GA. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010; 28:3-13; PMID:20713258; http://dx.doi.org/10.1016/j.vaccine.2010. 08.024.
75. Velan B, Kaplan G, Ziv A, Boyko V, Lerner-Geva L. Major motives in non-acceptance of A/H1N1 flu vaccination: the weight of rational assessment. Vaccine 2011; 29:1173-9; PMID:21167862; http://dx.doi.org/10.1016/j.vaccine. 2010.12.006.
76. Lin Y, Huang L, Nie S, Liu Z, Yu H, Yan W, et al. Knowledge, Attitudes and Practices KAP related to the Pandemic (H1N1) 2009 among Chinese General Population: a Telephone Survey. BMC Infect Dis 2011; 11:128; http://dx.doi.org/10.1186/1471-2334-11-128.
77. Centers for Disease Control and Prevention. Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010; 59:363-8; PMID:20360670.
78. Cohen D, Carter P. Conflicts of interest. WHO and the pandemic flu "conspiracies". BMJ 2010; 340:2912; PMID:20525679; http://dx.doi.org/10.1136/bmj.c2912.
79. Allan JL. The intention - behavior gap-it's all under control. Eur Health Psychol 2008; 10:62-4.
80. Yi S, Nonaka D, Nomoto M, Kobayashi J, Mizoue T. Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo. PLoS ONE 2011; 6:18893; PMID:21556152; http://dx.doi.org/10. 1371/journal.pone.0018893.
81. Brown JR, Goebel LJ, Neitch SM, Tweel HK, Mufson MA. Barriers to Vaccinating the Elderly With H1N1 Vaccine. Am J Med Sci 2011; 342:24-6; PMID:21537156; http://dx.doi.org/10.1097/MAJ.0b013e31820e782b.
82. Painter JE, Gargano LM, Sales JM, Morfaw C, Jones LM, Murray D, et al. Correlates of 2009 H1N1 influenza vaccine acceptability among parents and their adolescent children. Health Educ Res 2011; 26:751-60; PMID:21536717.
83. Frew PM, Hixson B, del Rio C, Esteves-Jaramillo A, Omer SB. Acceptance of pandemic 2009 influenza A (H1N1) vaccine in a minority population: determinants and potential points of intervention. Pediatrics 2011; 127:113-9; PMID:21502254; http://dx.doi.org/10.1542/peds.2010-1722Q.
84. Liao Q, Cowling BJ, Lam WW, Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS ONE 2011; 6:17713; PMID:21412418; http://dx.doi.org/10.1371/journal.pone.0017713.
85. Akis S, Velipasaoglu S, Camurdan AD, Beyazova U, Sahin F. Factors associated with parental acceptance and refusal of pandemic influenza A/H1N1 vaccine in Turkey. Eur J Pediatr 2011; 170:1165-72; PMID:21347848; http://dx.doi.org/10.1007/s00431-011-1425-6.
86. Setbon M, Le Pape MC, Létroublon C, Caille-Brillet AL, Raude J. The public's preventive strategies in response to the pandemic influenza A/H1N1 in France: distribution and determinants. Prev Med 2011; 52:178-81; PMID:21108960; http://dx.doi.org/10.1016/j.ypmed.2010.11.010.
87. Nikolakopoulou NM. H1N1 vaccine acceptance among parents in Greece. Int J Adolesc Med Health 2010; 22:339-40; PMID:21061936; http://dx.doi.org/10.1515/ IJAMH.2010.22.2.339.
88. Uscher-Pines L, Maurer J, Harris KM. Racial and Ethnic Disparities in Uptake and Location of Vaccination for 2009-H1N1 and Seasonal Influenza. Am J Public Health 2011; 101:1252-5; PMID:21566026; http://dx.doi.org/10.2105/AJPH. 2011.300133.
89. Kwon Y, Cho HY, Lee YK, Bae GR, Lee SG. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine 2010; 29:161-5; PMID:21055495; http://dx.doi.org/10.1016/j.vaccine.2010.10.063.
90. Maurer J, Harris KM, Parker A, Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of US adults. Vaccine 2009; 27:5732-4; PMID:19679219; http://dx.doi.org/10.1016/j.vaccine.2009.07.080.
91. Henrich N, Holmes B. What the public was saying about the H1N1 vaccine: perceptions and issues discussed in on-line comments during the 2009 H1N1 pandemic. PLoS ONE 2011; 6:18479; PMID:21533161; http://dx.doi.org/10.1371/ journal.pone.0018479.
92. Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, Van D, et al. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis 2010; 10:99; PMID:20403201; http://dx.doi.org/10. 1186/1471-2334-10-99.
93. Mavros MN, Mitsikostas PK, Kontopidis IG, Moris DN, Dimopoulos G, Falagas ME. H1N1v influenza vaccine in Greek medical students. Eur J Public Health 2011; 21:329-32; PMID:20833841; http://dx.doi.org/10.1093/eurpub/ckq109.
94. Kaboli F, Astrakianakis G, Li G, Guzman J, Donovan T, Naus M. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study. Infect Control Hosp Epidemiol 2010; 31:1017-24; PMID:20707670; http://dx.doi.org/10. 1086/655465.
95. Seeman N, Ing A, Rizo C. Assessing and responding in real time to online anti-vaccine sentiment during a flu pandemic. Healthc Q 2010; 13:8-15; PMID:20959725.
96. Gaygysyz Ü, Gaygysyz E, Özkan T, Lajunen T. Why were Turks unwilling to accept the A/H1N1 influenzapandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic. Vaccine 2010; 29:329-33; PMID:20979988; http://dx.doi.org/10.1016/ j.vaccine.2010.10.030.
97. Raude J, Caille-Brillet AL, Setbon M. The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr 2010; 2:1188; PMID:20972476; http://dx.doi.org/10.1371/currents.RRN1188.
98. Sypsa V, Livanios T, Psichogiou M, Malliori M, Tsiodras S, Nikolakopoulos I, et al. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill 2009; 14:19437; PMID:20003909.
99. Schwarzinger M, Verger P, Guerville MA, Aubry C, Rolland S, Obadia Y, et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? Vaccine 2010; 28:2743-8; PMID:20117271; http://dx.doi.org/10.1016/j.vaccine.2010.01.027.
100. Myers LB, Goodwin R. Determinants of adults' intention to vaccinate against pandemic swine flu. BMC Public Health 2011; 11:15; PMID:21211000; http://dx.doi.org/10.1186/1471-2458-11-15.
101. Horney JA, Moore Z, Davis M, MacDonald PD. Intent to receive pandemic influenza A (H1N1) vaccine, compliance with social distancing and sources of information in NC 2009. PLoS ONE 2010; 5:11226; PMID:20585462; http://dx.doi.org/10.1371/journal.pone.0011226.
102. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24; PMID:17380109.
103. Schwartz JL. HPV Vaccination's Second Act: Promotion, Competition and Compulsion. Am J Public Health 2010; 100:1841-4; PMID:20724671; http://dx.doi.org/10.2105/AJPH.2010.193060.
104. Bonanni P, Miriam L, Latham NB, Bechini A, Tiscione E, Lai P, et al. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin 2011; 7:128-35; PMID:21245659; http://dx.doi.org/10.4161/hv.7.0.14575.
105. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013.
106. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010; 28:4027-37; PMID:20412875; http://dx.doi.org/10.1016/j.vaccine.2010.03.063.
107. Dickerson JB, Smith ML, Ory MG. Increasing uptake of Gardasil among American adolescents: Comparisons with the history of Hepatitis B vaccination. Hum Vaccin 2011; 7:211-9; PMID:21311218; http://dx.doi.org/10.4161/hv.7.2.13633.
108. Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:630-2; PMID:20508594.
109. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 2010; 46:113-23; PMID:20113917; http://dx.doi.org/10.1016/j.jadohealth.2009.11. 199.
110. Hernandez BY, Wilkens LR, Thompson PJ, Shvetsov YB, Goodman MT, Ning L, et al. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin 2010; 6:467-75; PMID:20671442; http://dx.doi.org/10.4161/ hv.6.6.11279.
111. Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis 2010; 37:197-203; PMID:20118831; http://dx.doi.org/10.1097/OLQ.0b013e3181bf542c.
112. Reiter PL, McReea AL, Gottliebc SLT, Brewera NT. HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure. Vaccine 2010; 28:6292-7; PMID:20637770; http://dx.doi.org/10.1016/j.vaccine.2010.06.114.
113. Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sex Transm Infect 2011; 87:52-7; PMID:20956352; http://dx.doi.org/10.1136/sti.2009.041392.
114. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health 2010; 47:3-11; PMID:20547286; http://dx.doi.org/10.1016/j.jadohealth.2010.03.003.
115. McRee AL, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Biomarkers Prev 2010; 19:1937-44; PMID:20647398; http://dx.doi.org/10.1158/1055-9965.EPI-09-1287.
116. Mortensen GL. Parental attitudes towards vaccinating sons with human papillomavirus vaccine. Dan Med Bull 2010; 57:4230; PMID:21122463.
117. Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010; 29:232-40; PMID:20799510.
118. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-57; PMID:16991079; http://dx.doi.org/10.1086/507432.
119. Watts LA, Joseph N, Wall ace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol 2009; 112:577-82; PMID:19150120; http://dx.doi.org/10.1016/j.ygyno.2008.12.010.
120. Ferris DG, Waller JL, Miller J, Patel P, Price GA, Jackson L, et al. Variables associated with human papillomavirus (HPV) vaccine acceptance by men. J Am Board Fam Med 2009; 22:34-42; PMID:19124631; http://dx.doi.org/10.3122/ jabfm.2009.01.080008.
121. Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, et al. Men's attitudes toward receiving the human papillomavirus vaccine. J Low Genit Tract Dis 2008; 12:276-81; PMID:18820541; http://dx.doi.org/10.1097/LGT. 0b013e318167913e.
122. DiClemente RJ, Crosby RA, Salazar LF, Nash R. Younge SIs male intent to be vaccinated against HPV a function of the promotion message? Int J STD AIDS 2011; 22:332-4; PMID:21680669; http://dx.doi.org/10.1258/ijsa.2011.010429.
123. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis 2009; 36:58-62; PMID:18830138.
124. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401-11; PMID:21288094; http://dx.doi.org/10. 1056/NEJMoa0909537.
125. Malmqvist E, Helgesson G, Lehtinen J, Natunen K, Lehtinen M. The ethics of implementing human papillomavirus vaccination in developed countries. Med Health Care Philos 2011; 14:19-27; PMID:20853152; http://dx.doi.org/10.1007/ s11019-010-9285-9.
126. French KM, Barnabas RV, Lehtinen M, Kontula O, Pukkala E, Dillner J, et al. Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer 2007; 96:514-8; PMID:17245341; http://dx.doi.org/10.1038/sj.bjc. 6603575.
127. Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009; 85:148-9; PMID:19153110; http://dx.doi.org/10.1136/sti.2008.032581.